These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37085406)

  • 21. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsades de Pointes with QT prolongation related to donepezil use.
    Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
    J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology.
    Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C
    Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.
    Jardin CG; Putney D; Michaud S
    Ann Pharmacother; 2014 Feb; 48(2):196-202. PubMed ID: 24301687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of sevoflurane and ondansetron on QT interval and transmural dispersion of repolarization in children.
    Lee JH; Park YH; Kim JT; Kim CS; Kim HS
    Paediatr Anaesth; 2014 Apr; 24(4):421-5. PubMed ID: 24372925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.
    Lazzerini PE; Cantara S; Bertolozzi I; Accioli R; Salvini V; Cartocci A; D'Errico A; Sestini F; Bisogno S; Cevenini G; Capecchi M; Laghi-Pasini F; Castagna MG; Acampa M; Boutjdir M; Capecchi PL
    J Am Heart Assoc; 2022 Jan; 11(1):e023371. PubMed ID: 34935398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a single dose of i.v. ondansetron on QTc interval in emergency department patients.
    Li K; Vo K; Lee BK; Addo N; Coralic Z
    Am J Health Syst Pharm; 2018 Mar; 75(5):276-282. PubMed ID: 29317399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.
    Lynch DR; Washam JB; Newby LK
    Cardiol J; 2012; 19(4):434-8. PubMed ID: 22825908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
    Wei A; Peng J; Gu Z; Li J
    Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized, intuitive & visual QT-prolongation monitoring using patient-specific QTc threshold with pseudo-coloring and explainable AI.
    Alahmadi A; Davies A; Vigo M; Jay C
    J Electrocardiol; 2023; 81():218-223. PubMed ID: 37837739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
    Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
    Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic measures of repolarization heterogeneity are not predictive for Torsades de Pointes among undifferentiated patients with prolonged QTc: A case control study.
    Marill KA; Lopez S; Hark D; Spahr J; Shesh-Muthal K; Xue J; Rowlandson GI; Liu SW
    J Cardiovasc Electrophysiol; 2023 Jan; 34(1):166-176. PubMed ID: 36335640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
    Aslam W; Lamb CR; Ali N
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ondansetron Safety Regarding Prolong QTc for Children with Head Trauma.
    Assaad R; Pratt RE; Wrotniak BH; Qiao H; Territo HM
    J Emerg Med; 2023 May; 64(5):647-651. PubMed ID: 37061459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient.
    Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T
    Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
    Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
    J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loperamide Induced Recurrent Torsades de Pointes: A Case Report.
    Jackson GG; Lopez CR; Bermudez ES; Hill NE; Roden DM; Ely EW; Stollings JL
    J Pharm Pract; 2022 Oct; 35(5):791-795. PubMed ID: 33779357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
    Thomas SH; Behr ER
    Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.